• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精心整理的前列腺癌数据:在一个精心整理且协调一致的前列腺癌数据资源中整合临床、基因组和特征数据。

curatedPCaData: Integration of clinical, genomic, and signature features in a curated and harmonized prostate cancer data resource.

作者信息

Laajala Teemu D, Sreekanth Varsha, Soupir Alex, Creed Jordan, Calboli Federico Cf, Singaravelu Kalaimathy, Orman Michael, Colin-Leitzinger Christelle, Gerke Travis, Fidley Brooke L, Tyekucheva Svitlana, Costello James C

机构信息

Department of Mathematics and Statistics, University of Turku, Turku, Finland.

Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

出版信息

bioRxiv. 2023 Jan 19:2023.01.17.524403. doi: 10.1101/2023.01.17.524403.

DOI:10.1101/2023.01.17.524403
PMID:36711769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9882125/
Abstract

Genomic and transcriptomic data have been generated across a wide range of prostate cancer (PCa) study cohorts. These data can be used to better characterize the molecular features associated with clinical outcomes and to test hypotheses across multiple, independent patient cohorts. In addition, derived features, such as estimates of cell composition, risk scores, and androgen receptor (AR) scores, can be used to develop novel hypotheses leveraging existing multi-omic datasets. The full potential of such data is yet to be realized as independent datasets exist in different repositories, have been processed using different pipelines, and derived and clinical features are often not provided or unstandardized. Here, we present the R package, a harmonized data resource representing >2900 primary tumor, >200 normal tissue, and >500 metastatic PCa samples across 19 datasets processed using standardized pipelines with updated gene annotations. We show that meta-analysis across harmonized studies has great potential for robust and clinically meaningful insights. is an open and accessible community resource with code made available for reproducibility.

摘要

在广泛的前列腺癌(PCa)研究队列中已经生成了基因组和转录组数据。这些数据可用于更好地表征与临床结果相关的分子特征,并在多个独立的患者队列中检验假设。此外,诸如细胞组成估计、风险评分和雄激素受体(AR)评分等衍生特征,可用于利用现有的多组学数据集提出新的假设。由于独立数据集存在于不同的存储库中,使用不同的流程进行处理,并且衍生特征和临床特征通常未提供或未标准化,此类数据的全部潜力尚未实现。在这里,我们展示了R包,这是一个经过协调的数据资源,它代表了超过2900个原发性肿瘤、超过200个正常组织以及超过500个转移性PCa样本,这些样本来自19个使用标准化流程和更新的基因注释处理的数据集。我们表明,跨协调研究的荟萃分析对于获得可靠且具有临床意义的见解具有巨大潜力。 是一个开放且可访问的社区资源,提供了代码以实现可重复性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec4/9882125/04ac70842af1/nihpp-2023.01.17.524403v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec4/9882125/0f0928d8b3f1/nihpp-2023.01.17.524403v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec4/9882125/065fb7c698a7/nihpp-2023.01.17.524403v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec4/9882125/04ac70842af1/nihpp-2023.01.17.524403v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec4/9882125/0f0928d8b3f1/nihpp-2023.01.17.524403v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec4/9882125/065fb7c698a7/nihpp-2023.01.17.524403v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec4/9882125/04ac70842af1/nihpp-2023.01.17.524403v1-f0003.jpg

相似文献

1
curatedPCaData: Integration of clinical, genomic, and signature features in a curated and harmonized prostate cancer data resource.精心整理的前列腺癌数据:在一个精心整理且协调一致的前列腺癌数据资源中整合临床、基因组和特征数据。
bioRxiv. 2023 Jan 19:2023.01.17.524403. doi: 10.1101/2023.01.17.524403.
2
A harmonized resource of integrated prostate cancer clinical, -omic, and signature features.一个整合了前列腺癌临床、组学和特征的协调资源。
Sci Data. 2023 Jul 5;10(1):430. doi: 10.1038/s41597-023-02335-4.
3
Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.基质基因表达可预测转移性原发性前列腺癌。
Eur Urol. 2018 Apr;73(4):524-532. doi: 10.1016/j.eururo.2017.02.038. Epub 2017 Mar 19.
4
Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.前列腺癌基因表达数据的荟萃分析确定了一种富含糖基化酶的新型鉴别特征。
BMC Med Genomics. 2014 Dec 31;7:513. doi: 10.1186/s12920-014-0074-9.
5
A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer.机器学习框架开发了一种 DNA 复制应激模型,用于预测原发性前列腺癌的临床结果和治疗脆弱性。
J Transl Med. 2023 Jan 12;21(1):20. doi: 10.1186/s12967-023-03872-7.
6
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.局部和转移性前列腺癌中神经肽 Y 表达的转录组和临床特征:具有临床意义的新型前列腺癌亚型的鉴定。
Eur Urol Oncol. 2019 Jul;2(4):405-412. doi: 10.1016/j.euo.2019.05.001. Epub 2019 Jun 2.
7
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.B7-H3 表达与前列腺癌的种族起源、免疫细胞密度和雄激素受体激活的关联。
Cancer. 2022 Jun 15;128(12):2269-2280. doi: 10.1002/cncr.34190. Epub 2022 Mar 25.
8
PROTEOMAS: a workflow enabling harmonized proteomic meta-analysis and proteomic signature mapping.蛋白质组分析系统:一种实现蛋白质组元分析与蛋白质组特征图谱绘制协调统一的工作流程。
J Cheminform. 2023 Mar 19;15(1):34. doi: 10.1186/s13321-023-00710-2.
9
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.TMEFF2 调控的细胞周期相关基因特征可预测前列腺癌的复发风险。
BMC Cancer. 2019 May 6;19(1):423. doi: 10.1186/s12885-019-5592-6.
10
Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy.局部前列腺癌根治术后男性患者中,HOXB13 表达与转移进展相关。
Eur Urol Oncol. 2021 Dec;4(6):955-962. doi: 10.1016/j.euo.2020.05.001. Epub 2020 Jun 12.